Baxter - 39 Year Stock Price History | BAX

Historical daily share price chart and data for Baxter since 1981 adjusted for splits. The latest closing stock price for Baxter as of January 22, 2020 is 91.16.
  • The all-time high Baxter stock closing price was 91.16 on January 22, 2020.
  • The Baxter 52-week high stock price is 91.86, which is 0.8% above the current share price.
  • The Baxter 52-week low stock price is 69.86, which is 23.4% below the current share price.
  • The average Baxter stock price for the last 52 weeks is 80.96.
Baxter Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 87.9579 85.8700 91.1600 85.2900 91.1600 9.02%
2019 79.7233 65.3000 89.7800 64.4800 83.6200 27.04%
2018 69.8944 67.1700 77.8000 61.4500 65.8200 1.83%
2017 58.0264 44.4400 66.0500 44.4400 64.6400 45.78%
2016 43.8994 37.1700 49.1600 34.7600 44.3400 16.23%
2015 52.9969 73.3100 73.3100 32.2700 38.1500 -47.95%
2014 72.2730 69.1900 77.0000 66.4900 73.2900 5.38%
2013 69.3542 67.6500 74.4300 63.8900 69.5500 4.34%
2012 58.0275 50.5400 68.8100 49.0300 66.6600 34.72%
2011 54.3502 50.5500 62.4100 47.6500 49.4800 -2.25%
2010 49.9003 58.2900 61.7100 40.4700 50.6200 -13.74%
2009 54.0204 55.0800 60.5000 46.4100 58.6800 9.50%
2008 61.4454 57.7900 71.1500 48.5000 53.5900 -7.68%
2007 54.7795 46.5000 61.0900 46.3300 58.0500 25.13%
2006 40.9353 38.3600 47.2100 35.4500 46.3900 23.21%
2005 37.2682 34.6200 40.9500 33.3700 37.6500 9.00%
2004 31.4834 30.1700 34.5900 28.7600 34.5400 13.17%
2003 26.5794 28.6900 31.2000 18.5600 30.5200 9.00%
2002 43.1442 53.1000 59.6000 24.2200 28.0000 -47.79%
2001 48.4272 44.8150 55.5000 40.7500 53.6300 21.46%
2000 35.8150 30.6900 44.4400 25.9050 44.1550 40.60%
1999 32.7239 31.5950 37.9700 29.3450 31.4050 -2.24%
1998 28.6442 25.0650 33.0000 24.3450 32.1250 27.38%
1997 25.1378 20.3150 29.7500 20.3150 25.2200 23.02%
1996 21.9332 20.8100 23.9375 20.0000 20.5000 -2.10%
1995 17.7909 14.0650 21.2500 13.5650 20.9400 46.95%
1994 12.7748 12.1900 14.3150 11.0000 14.2500 16.90%
1993 13.4814 15.9400 15.9400 10.1250 12.1900 -24.71%
1992 17.9988 19.6250 20.0650 15.3750 16.1900 -19.05%
1991 16.9144 13.6900 20.1900 12.8150 20.0000 43.47%
1990 12.3140 12.7500 14.5000 10.3150 13.9400 11.52%
1989 10.7476 8.8100 12.8100 8.8100 12.5000 41.88%
1988 10.3560 11.6850 12.9350 8.2500 8.8100 -22.55%
1987 12.1138 9.5000 14.5600 9.1850 11.3750 18.18%
1986 9.0744 7.7500 10.5600 7.6250 9.6250 22.22%
1985 7.3046 6.5650 8.3100 6.2500 7.8750 19.95%
1984 8.1495 11.6250 12.2500 6.0000 6.5650 -43.53%
1983 13.3763 11.5925 15.6575 10.6850 11.6250 -3.89%
1982 9.6983 8.5625 12.6250 7.8125 12.0950 44.42%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $46.542B $11.127B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $162.450B 28.35
Medtronic (MDT) Ireland $162.306B 22.42
Stryker (SYK) United States $81.207B 27.30
Boston Scientific (BSX) United States $61.398B 28.98
Essilor Luxottica (ESLOY) France $33.935B 0.00
Zimmer Biomet Holdings (ZBH) United States $31.054B 19.48
Lonza Group Ag (LZAGY) Switzerland $30.726B 0.00
Terumo (TRUMY) Japan $27.631B 34.48
Coloplast (CLPBY) Denmark $27.475B 42.40
ResMed (RMD) United States $23.636B 43.60
Smith & Nephew SNATS (SNN) United Kingdom $21.789B 0.00
Sunny Optical Technology (SNPTF) China $20.017B 0.00
Insulet (PODD) United States $11.820B 562.35
Bio-Rad Laboratories (BIO) United States $11.331B 54.38
Canopy Growth (CGC) Canada $8.412B 0.00
Perrigo (PRGO) Ireland $8.096B 15.10
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Hill-Rom Holdings (HRC) United States $7.608B 22.37
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
GN STORE NORD (GNNDY) Denmark $6.158B 31.81
Haemonetics (HAE) United States $5.859B 39.59
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.053B 31.92
ICU Medical (ICUI) United States $4.016B 26.18
Neogen (NEOG) United States $3.682B 61.28
GW Pharmaceuticals (GWPH) United Kingdom $3.537B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.427B 0.00
Agios Pharmaceuticals (AGIO) United States $3.169B 0.00
Quidel (QDEL) United States $3.142B 29.82
National Vision Holdings (EYE) United States $2.772B 62.57
Aurora Cannabis (ACB) Canada $2.223B 0.00
Cardiovascular Systems (CSII) United States $1.893B 0.00
AtriCure (ATRC) United States $1.510B 0.00
InMode (INMD) Israel $1.476B 0.00
Aphria (APHA) $1.443B 0.00
TG Therapeutics (TGTX) United States $1.341B 0.00
VAREX IMAGING (VREX) United States $1.194B 23.86
NanoString Technologies (NSTG) United States $1.061B 0.00
Phibro Animal Health (PAHC) United States $1.035B 19.38
PetIQ (PETQ) United States $0.857B 20.90
Eagle Pharmaceuticals (EGRX) United States $0.792B 30.32
Lantheus Holdings (LNTH) United States $0.736B 18.39
LeMaitre Vascular (LMAT) United States $0.736B 41.36
Quanterix (QTRX) United States $0.710B 0.00
Omeros (OMER) United States $0.672B 0.00
Cerus (CERS) United States $0.603B 0.00
MacroGenics (MGNX) United States $0.575B 0.00
Surmodics (SRDX) United States $0.563B 58.31
OraSure Technologies (OSUR) United States $0.504B 30.26
Organigram Holdings (OGI) Canada $0.477B 0.00
Owens & Minor (OMI) United States $0.423B 15.65
Meridian Bioscience (VIVO) United States $0.419B 14.38
HEXO (HEXO) $0.389B 0.00
Utah Medical Products (UTMD) United States $0.388B 28.14
Zynex (ZYXI) United States $0.348B 39.37
BioLife Solutions (BLFS) United States $0.311B 126.67
Female Health (VERU) United States $0.297B 0.00
Bovie Medical (APYX) United States $0.283B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.282B 0.00
Repro-Med Systems (KRMD) United States $0.250B 0.00
Vapotherm (VAPO) United States $0.246B 0.00
United Health Products (UEEC) United States $0.229B 0.00
Viemed Healthcare (VMD) United States $0.213B 22.40
Liberty Health Sciences (LHSIF) Canada $0.180B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.175B 0.00
InfuSystems Holdings (INFU) United States $0.173B 874.00
Rockwell Medical (RMTI) United States $0.168B 0.00
Cytosorbents (CTSO) United States $0.149B 0.00
Fonar (FONR) United States $0.134B 9.48
Chimerix (CMRX) United States $0.123B 0.00
Surface Oncology (SURF) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
MTech Acquisition (KERN) United States $0.093B 0.00
United-Guardian (UG) United States $0.083B 21.10
MRI Interventions (MRIC) United States $0.079B 0.00
Nephros (NEPH) United States $0.076B 0.00
Chembio Diagnostics (CEMI) United States $0.068B 0.00
FSD PHARMA INC (HUGE) $0.053B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Trinity Biotech (TRIB) Ireland $0.030B 0.00
NF Energy Saving (BIMI) China $0.025B 0.00
GUARDION HEALTH (GHSI) United States $0.024B 0.00
Senestech (SNES) United States $0.016B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.015B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
Myomo (MYO) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00